- Home
- EVAX vs BGFV Comparison
EVAX vs BGFV Comparison
Compare EVAX & BGFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- BGFV
- Stock Information
- Founded
- EVAX 2008
- BGFV 1955
- Country
- EVAX Denmark
- BGFV United States
- Employees
- EVAX N/A
- BGFV N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- BGFV Other Specialty Stores
- Sector
- EVAX Health Care
- BGFV Consumer Discretionary
- Exchange
- EVAX Nasdaq
- BGFV Nasdaq
- Market Cap
- EVAX 16.3M
- BGFV 19.5M
- IPO Year
- EVAX 2021
- BGFV N/A
- Fundamental
- Price
- EVAX $1.64
- BGFV $1.23
- Analyst Decision
- EVAX Strong Buy
- BGFV
- Analyst Count
- EVAX 2
- BGFV 0
- Target Price
- EVAX $10.00
- BGFV N/A
- AVG Volume (30 Days)
- EVAX 64.1K
- BGFV 515.2K
- Earning Date
- EVAX 05-27-2025
- BGFV 04-29-2025
- Dividend Yield
- EVAX N/A
- BGFV 3.88%
- EPS Growth
- EVAX N/A
- BGFV N/A
- EPS
- EVAX N/A
- BGFV N/A
- Revenue
- EVAX $3,344,000.00
- BGFV $777,688,000.00
- Revenue This Year
- EVAX $102.45
- BGFV N/A
- Revenue Next Year
- EVAX $100.30
- BGFV N/A
- P/E Ratio
- EVAX N/A
- BGFV N/A
- Revenue Growth
- EVAX 4480.82
- BGFV N/A
- 52 Week Low
- EVAX $1.20
- BGFV $0.80
- 52 Week High
- EVAX $20.81
- BGFV $4.10
- Technical
- Relative Strength Index (RSI)
- EVAX 55.67
- BGFV 61.78
- Support Level
- EVAX $1.42
- BGFV $0.87
- Resistance Level
- EVAX $1.62
- BGFV $1.78
- Average True Range (ATR)
- EVAX 0.11
- BGFV 0.13
- MACD
- EVAX 0.03
- BGFV 0.05
- Stochastic Oscillator
- EVAX 62.86
- BGFV 42.11
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About BGFV Big 5 Sporting Goods Corporation
Big 5 Sporting Goods Corp is a specialty retailer company that is principally engaged in the sale of sporting goods in the Western United States. Its product mix includes athletic shoes, apparel, and accessories, as well as a broad selection of outdoor and athletic equipment for team sports, fitness, camping, hunting, fishing, tennis, golf, winter and summer recreation and roller sports. The company operates solely as a sporting goods retailer, which includes both its retail stores and an e-commerce platform. The company operates a distribution center located in Riverside, California, that services all of its stores and e-commerce platform.